Long Position on SDGR @ $68.25 on 6/1/2020 (Momentum)

Schrödinger, Inc. (SDGR) provides computational platform to accelerate drug discovery and materials design for biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide.

The company operates through two segments, Software and Drug Discovery.

IT segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.

The Drug Discovery segment develops a pipeline of preclinical and clinical drug discovery programs through its computational platform in collaboration with pharmaceutical companies.

Schrödinger, Inc. has a strategic collaboration with Twist Bioscience Corporation. 

Schrodinger reported a 1st Quarter March 2020 loss of $0.34 per share on revenue of $26.2 million. The consensus estimate was a loss of $0.21 per share on revenue of $21.9 million.

This stock should continue to see a rise in share prices as the trendline on its chart suggests.

Entry point: $68.25

52-week trade range: $25.50 - $75.60

Stop/Loss: $65.50

Target Price: $76.00

Updates

6/17/2020 2:20:11 PM

SDGR closed at $76.00

Position closed on 6/17/2020 at price of $76.00 with a 11.36% gain in 16 days.

Back to Portfolio